NEW YORK, Feb. 9, 2017 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of USANA Health Sciences, Inc. (NYSE: USNA) concerning possible violations of federal securities laws.
On February 7, 2017, post-market, USANA disclosed that "[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. The investigation focuses on compliance with the Foreign Corrupt Practices Act . . . and certain conduct and policies at BabyCare, including BabyCare's expense reimbursement policies." Upon this news, shares of USANA were down more than 10% on intraday trading on February 8, 2017. To obtain additional information, go to:
or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/investor-alert-levi--korsinsky-llp-announces-the-commencement-of-an-investigation-involving-possible-securities-fraud-violations-by-the-board-of-directors-of-usana-health-sciences-inc----usna-300405109.html
SOURCE Levi & Korsinsky, LLP